JMP Securities raised the firm’s price target on Dave (DAVE) to $115 from $75 and keeps an Outperform rating on the shares. Dave’s ...

JMP Securities lowered the firm’s price target on OptimizeRx (OPRX) to $8 from $16 and keeps an Outperform rating on the shares.

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

JMP Securities raised the firm’s price target on Atlanticus (ATLC) to $54 from $45 and keeps an Outperform rating on the ...

JMP Securities lowered the firm’s price target on Angi Inc. (ANGI) to $3 from $3.25 and keeps an Outperform rating on the ...

Fintel reports that on November 11, 2024, JMP Securities downgraded their outlook for agilon health (NYSE:AGL) from Market ...

On Wednesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.66 which represents a decrease of $-0.18 or -6.34% from the prior close of $2.84. The stock opened at $2.88 and ...

On Wednesday, Savara Inc (SVRA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.58 or -15.14% from the prior close of $3.83. The stock opened at $3.67 and touched a low ...

Ibotta posted third-quarter adjusted earnings of 94 cents per share, which may not compare to market estimates of 35 cents ...

CyberArk Software (NASDAQ:CYBR – Get Free Report)‘s stock had its “market outperform” rating reiterated by investment ...

Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...

On Monday, JMP Securities initiated coverage on Instil Bio Inc (NASDAQ:TIL) shares with a Market Perform rating. Instil Bio, which went public with an initial public offering as a company ...